Brief: Vitrolife Q2 EBITDA Up At SEK 327 Mln
July 17 (Reuters) - Vitrolife AB VITR.ST :
* INTERIM REPORT Q2, 2024: STRONG TECHNOLOGIES GROWTH AND
IMPROVED
MARGINS
* Q2 SALES OF SEK 941 (905) MILLION, AN INCREASE OF 4% IN
LOCAL
CURRENCIES AND 4% IN SEK
* Q2 OPERATING INCOME BEFORE DEPRECIATION AND AMORTISATION
(EBITDA) INCREASED TO SEK 327 (293) MILLION
Source text for Eikon: ID:nWkr9FjNBm
Further company coverage: VITR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))